R&D
Research center and vivarium for preclinical tests allow Petrovax to carry out a full cycle of development and implementation of medicinal products.
The company's investment program provides for the financing of advanced R&D projects.
![](/upload/medialibrary/4c4/ib1eht50hifyj9l1g2br0l54nwyeq11o/rd_mobile.jpg)
petrovax’s development concept is based on the production of original products
The structure of R&D department allows managing the molecule inception and product lifecycle from the idea to implementation in medical practice. We involve leading Russian and foreign specialized research institutions in highly specialized studies.
![](/local/images/2022/rnd/concept/1.jpg)
![](/local/images/2022/rnd/concept/2.jpg)
areas of activities
![](/local/images/2022/rnd/directions/1.jpg)
Search for innovative molecules and conducting preclinical studies
![](/local/images/2022/rnd/directions/2.jpg)
In-depth study of the mechanism of action in terms of the pathogenesis of a corresponding disease
![](/local/images/2022/rnd/directions/3.jpg)
Proof of the safety and efficacy of drugs in preclinical studies
![](/local/images/2022/rnd/directions/4.jpg)
Development of quality control methods and manufacturing technologies
![](/local/images/2022/rnd/directions/5.jpg)
Conducting of clinical studies in accordance with GCP standards
![](/local/images/2022/rnd/directions/6.jpg)
Introduction of innovative technologies, development and optimization of manufacturing processes
in-house vivarium
Petrovax has a certified modern vivarium for preclinical studies to assess drug efficacy and safety of original medicines. Preclinical data from in-house studies form the basis for marketing authorization applications for the drugs developed by Petrovax.
![](/local/images/2022/rnd/vivarium/mobile.jpg)